Abstract
Though international organizations like the United Nations have made definitive declarations regarding the human rights implications of intellectual property rights and specifically rights to the human genome, the international outcry about patenting isolated human genes has been minimal. Specifically, it is yet to be determined how the international human rights community will respond to the view of U.S. courts that genes are patentable subject matter. If the U.S. Supreme Court eventually hears the Myriad case, its decision will likely draw international attention as a landmark intellectual property decision. If the Court does hear the case, chances are the international human rights implications will not be the Justices’ primary consideration. But regardless of what decision the Court makes and what legal arguments it uses to support its decisions, it is likely that there will be a response from the international human rights community, especially if the Court finds Myriad’s patents valid.
Recommended Citation
Abbott, Laurie E.
(2012)
"Incentive for Innovation or Invitation to Inhumanity?: A Human Rights Analysis of Gene Patenting and the Case of Myriad Genetics,"
Utah Law Review: Vol. 2012:
No.
1, Article 11.
Available at:
https://dc.law.utah.edu/ulr/vol2012/iss1/11